Potassium Concentrations in Transgender Women Using Spironolactone: A Retrospective Chart Review.

Pranav Gupta,Pichatorn Suppakitjanusant, Mary Stevenson,Michael Goodman,Vin Tangpricha

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists（2022）

引用 0|浏览0

暂无评分

摘要

No participant had laboratory evidence of significant hyperkalemia (K > 5.5 mmol/L) after initiation of spironolactone. Frequent measurement of potassium concentrations might be unnecessary in transgender women taking spironolactone in patients with serum creatinine levels of <2 mg/dL.

查看译文

关键词

gender-affirming care,gender-affirming hormonal therapy,spironolactone,transgender

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要